GlassScriptPhysician profile
Arjun K Theertham
NPI 1679956981
$102,336.55
in general payments reported to CMS, 2019-2025
20 companies · $4,956 in 2025
The $4,956 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,558 · 2020: $1,266 · 2021: $52K · 2022: $24K · 2023: $12K · 2024: $5,506 · 2025: $4,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,139.98 |
| Food and Beverage | $10,109.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $53,469.93 | 2019-2025 | Aveir, Ensite Precision, Ensite |
| Medtronic, INC. | $25,260.30 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan |
| Biotronik INC. | $11,190.43 | 2019-2023 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Solia |
| Boston Scientific Corporation | $3,178.73 | 2021-2025 | Rhythmia Mapping System, Lux-Dx Insertable Cardiac Monitor, Resonate El Icd Vr |
| Medical Device Business Services, INC. | $2,372.47 | 2023 | Carto 3 |
| Philips North America LLC | $2,223.66 | 2023-2025 | Lm Undivided, (9124) Lm Undivided, (Am5) Lead Management |
| Biosense Webster, INC. | $1,949.07 | 2021-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Pfizer INC. | $527.36 | 2019-2024 | |
| Abiomed | $524.05 | 2020-2025 | |
| Baylis Medical Company INC | $473.84 | 2021 | |
| Esperion Therapeutics, INC. | $250.10 | 2021 | |
| Cardiva Medical, INC. | $223.63 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Astrazeneca Pharmaceuticals LP | $200.68 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $153.17 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $134.73 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $99.00 | 2020 | |
| Medicomp INC | $57.56 | 2025 | Telepatch Cardiac Monitor |
| Cordis US Corp. | $18.63 | 2025 | Mynx Control Venous |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.02 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Theertham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.